X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Novartis - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS NOVARTIS DR. DATSONS LABS/
NOVARTIS
 
P/E (TTM) x -10.9 364.8 - View Chart
P/BV x 0.2 18.0 0.9% View Chart
Dividend Yield % 0.0 1.6 -  

Financials

 DR. DATSONS LABS   NOVARTIS
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
NOVARTIS
Mar-16
DR. DATSONS LABS/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs126982 12.8%   
Low Rs31556 5.6%   
Sales per share (Unadj.) Rs133.0252.9 52.6%  
Earnings per share (Unadj.) Rs0.262.1 0.2%  
Cash flow per share (Unadj.) Rs6.663.3 10.4%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs128.8363.6 35.4%  
Shares outstanding (eoy) m31.6631.96 99.1%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.0 19.3%   
Avg P/E ratio x516.112.4 4,170.3%  
P/CF ratio (eoy) x11.812.2 97.5%  
Price / Book Value ratio x0.62.1 28.7%  
Dividend payout %016.1 0.0%   
Avg Mkt Cap Rs m2,47724,580 10.1%   
No. of employees `000NA0.8 0.0%   
Total wages/salary Rs m561,801 3.1%   
Avg. sales/employee Rs ThNM10,748.9-  
Avg. wages/employee Rs ThNM2,395.2-  
Avg. net profit/employee Rs ThNM2,641.1-  
INCOME DATA
Net Sales Rs m4,2118,083 52.1%  
Other income Rs m79829 9.5%   
Total revenues Rs m4,2898,913 48.1%   
Gross profit Rs m569234 242.8%  
Depreciation Rs m20437 556.9%   
Interest Rs m4302 23,900.0%   
Profit before tax Rs m131,025 1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-217 -10.8%   
Extraordinary Inc (Exp) Rs m01,696 0.0%   
Tax Rs m6752 0.8%   
Profit after tax Rs m51,986 0.2%  
Gross profit margin %13.52.9 466.1%  
Effective tax rate %48.073.4 65.5%   
Net profit margin %0.124.6 0.5%  
BALANCE SHEET DATA
Current assets Rs m6,85212,678 54.0%   
Current liabilities Rs m6,7112,433 275.8%   
Net working cap to sales %3.3126.7 2.6%  
Current ratio x1.05.2 19.6%  
Inventory Days Days16133 492.0%  
Debtors Days Days31822 1,416.2%  
Net fixed assets Rs m3,67369 5,307.8%   
Share capital Rs m317160 198.1%   
"Free" reserves Rs m3,76111,460 32.8%   
Net worth Rs m4,07811,621 35.1%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63314,400 87.7%  
Interest coverage x1.0570.5 0.2%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.30.6 59.4%   
Return on assets %3.413.8 24.9%  
Return on equity %0.117.1 0.7%  
Return on capital %7.723.6 32.5%  
Exports to sales %22.90.7 3,074.2%   
Imports to sales %14.318.6 76.9%   
Exports (fob) Rs m96460 1,601.3%   
Imports (cif) Rs m6021,503 40.1%   
Fx inflow Rs m964186 517.4%   
Fx outflow Rs m6071,821 33.3%   
Net fx Rs m357-1,635 -21.8%   
CASH FLOW
From Operations Rs m1,3452,531 53.1%  
From Investments Rs m-2,256-8,270 27.3%  
From Financial Activity Rs m-1,200-386 311.1%  
Net Cashflow Rs m-2,111-6,125 34.5%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 2.0 -  
FIIs % 1.4 1.6 84.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 21.5 437.7%  
Shareholders   20,807 41,647 50.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  FULFORD INDIA  ORCHID PHARMA LTD  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

Matrimony.com (IPO)

Sep 11, 2017

Should you subscribe to the IPO of Matrimony.com?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS